Cockayne syndrome and xeroderma pigmentosum

  title={Cockayne syndrome and xeroderma pigmentosum},
  author={Isabelle Rapin and Yelena Lindenbaum and Dennis W. Dickson and Kenneth H. Kraemer and Jay H. Robbins},
  pages={1442 - 1449}
Objectives: To review genetic variants of Cockayne syndrome (CS) and xeroderma pigmentosum (XP), autosomal recessive disorders of DNA repair that affect the nervous system, and to illustrate them by the first case of xeroderma pigmentosum–Cockayne syndrome (XP-CS) complex to undergo neuropathologic examination. Methods: Published reports of clinical, pathologic, and molecular studies of CS, XP neurologic disease, and the XP-CS complex were reviewed, and a ninth case of XP-CS is summarized… 

Figures and Tables from this paper

Xeroderma pigmentosum-Cockayne syndrome complex
Although health problems in XP-CS vary both in severity and in when they the first occur, there was overall homogeneity between all complementation groups and putative severity groups.
Unexpected occurrence of xeroderma pigmentosum in an uncle and nephew.
A boy who was found to have XP after a severe burn following minimal sun exposure is described, and his maternal uncle, now age 20 years, has the typical skin pigmentary findings of XP along with severe progressive neurologic involvement.
[Xeroderma pigmentosum: children of the moon].
Xeroderma pigmentosum is a rare disorder, which is transmitted in an autosomal recessive manner, and must be distinguished from other so-called DNA repair deficiency syndromes, including Cockayne syndrome and trichothiodystrophy.
Neurological symptoms and natural course of xeroderma pigmentosum.
We have prospectively followed 16 Finnish xeroderma pigmentosum (XP) patients for up to 23 years. Seven patients were assigned by complementation analysis to the group XP-A, two patients to the XP-C
Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.
Three newly diagnosed xeroderma pigmentosum complementation group G patients with markedly different clinical features showed marked reductions in post-ultraviolet cell survival and DNA repair but these were higher in XP65BE than in XP82DC, and XP96TA fibroblasts had very low XPG mRNA expression levels whereasXP65BE fibroblast levels had nearly normal levels.
Xeroderma Pigmentosum - Cockayne Syndrome Complex (XP-CS) - Another case.
The case of a 3-year old girl with clinical manifestations typical of XP-CS, an extremely rare combination of Xeroderma Pigmentosum and Cockayne Syndrome, shows that the diagnosis ofXP-CS can be based on clinical features and MRI findings when the genetic testing is not available.
Cockayne's syndrome: a case report. Literature review.
The aim of this review is to show the dentistry community the characteristics of the Cockayne s syndrome by means of a clinical case.


Xeroderma pigmentosum--Cockayne syndrome complex: a further case.
In cases suspected of having COFS syndrome and early onset CS, extensive DNA repair studies are needed to reach the definitive diagnosis, thereby allowing reliable genetic counselling and prenatal diagnosis.
Xeroderma pigmentosum complementation group G associated with Cockayne syndrome.
It is concluded that the syndromes XP and CS are biochemically closely related and may be part of a broader clinical disease spectrum and suggested, as a possible molecular mechanism underlying this relation, that the XPGC repair gene has an additional vital function, as shown for some other NER genes.
Cockayne Syndrome: Clinicopathologic and Tissue Culture Studies of Affected Siblings
It is suggested that the DNA-repair defect of CS caused abnormalities in nuclear DNA replication and cell division which result in cell death and in the observed nuclear abnormalities.
Cockayne syndrome: review of 140 cases.
Cockayne Syndrome is an uncommon but devastating genetic condition which will be better understood as the biochemical interrelationships between DNA replication and repair, and between growth, homeostasis, and oncogenesis are unraveled.
Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form.
The functional capacity of these patients' cultured fibroblast strains to survive after treatment with ultraviolet radiation indicates that their DNA repair defect is less severe than that of typical group A patients who have a more severe neurodegeneration with an earlier symptomatic onset.
A summary of mutations in the UV‐sensitive disorders: Xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy
The summary presented here represents currently known mutations that can be used as the basis for future studies of the structure, function, and biochemical properties of the proteins involved in this set of complex disorders, and may allow determination of the critical sites for mutations leading to different clinical manifestations.
Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases.
Quantitative frequencies of clinical abnormalities in xeroderma pigmentosum were estimated by abstracting published descriptions of 830 patients in 297 articles obtained from a survey of the medical literature from 1874 to 1982, finding scant information concerning the efficacy of any therapeutic regimen.
Genetic heterogeneity of the excision repair defect associated with trichothiodystrophy.
Observations, which give the first indication that TTD is associated with repair defects behaving differently in the functional test of complementation, suggest some kind of causal connection between defective excision-repair factors and clinical features diagnostic for TTD.